Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Insiderhandel: Vorstand kauft Aktien von SBF im Wert von 12000 EUR (Insiderkauf) +++ SBF AG Aktie -4,13%

QUEST DIAGNOSTICS Aktie

 >Aktienkurs 
200.5 EUR    -6.1%    (TradegateBSX)
Ask: 204.5 EUR / 100 Stück
Bid: 200.5 EUR / 100 Stück
Tagesumsatz: 1 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
Aktie über LYNX handeln
>Performance
1 Woche: +7,3%
1 Monat: +3,5%
3 Monate: +27,7%
6 Monate: +28,0%
1 Jahr: +39,0%
laufendes Jahr: +45,3%
>QUEST DIAGNOSTICS Aktie
Name:  QUEST DIAGNOSTICS DL-,01
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US74834L1008 / 904533
Symbol/ Ticker:  QDI (Frankfurt) / DGX (NYSE)
Kürzel:  FRA:QDI, ETR:QDI, QDI:GR, NYSE:DGX
Index:  S&P500
Profil:  Quest Diagnostics Incorporated is a healthcare diagnostics company that provides diagnostic testing and related information services. Quest Diagnostics supports physicians, hospitals, patients, health plans, employers, and government agencies with ro..
>Volltext..
Marktkapitalisierung:  23683.87 Mio. EUR
Unternehmenswert:  29056.12 Mio. EUR
Umsatz:  10065.08 Mio. EUR
EBITDA:  1970.35 Mio. EUR
Nettogewinn:  921.18 Mio. EUR
Gewinn je Aktie:  8.3 EUR
Schulden:  5557.56 Mio. EUR
Liquide Mittel:  545.05 Mio. EUR
Operativer Cashflow:  1656.91 Mio. EUR
Bargeldquote:  0.35
Umsatzwachstum:  13.32%
Gewinnwachstum:  15.48%
Dividende je Aktie:  2.86 EUR
Dividendenrendite:  1.34%
Dividendenschätzung:  1.4%
Div. Historie:  08.07.26 - 0.752672€
07.04.26 - 0.733752€
>weitere anzeigen...
Insiderhandel 2 Insider verkauften innerhalb der letzten 30 Tage Aktien im Wert von 6.921.929 Euro.
Suchwörter:  QUEST DIAGNOSTICS, QUEST DIAGNOSTIC
Letzte Datenerhebung:  22.09.26
>Kennzahlen
Aktien/ Unternehmen:
Aktien: 110.37 Mio. St.
Frei handelbar: 99.52%
Rückkaufquote: 1.6%
Mitarbeiter: 57000
Umsatz/Mitarb.: 0.17 Mio. EUR
Analysten:
Analystenrating: Buy
Kursziel: 1.61%
Bewertung:
KGV: 26.02
KGV lG: 22.03
KUV: 2.39
KBV: 3.59
PEG-Ratio: 2.05
EV/EBITDA: 14.75
Rentabilität:
Bruttomarge: 31.87%
Gewinnmarge: 9.15%
Operative Marge: 14.56%
Managementeffizenz:
Gesamtkaprendite: 6.43%
Eigenkaprendite: 14.35%
>Peer Group
Gesundheit, Infektionskrankheiten/ Impfstoffentwicklung/ Antibiotika, Stoffwechselerkrankungen (Diabetes/ Adipositas), Onkologie/ Krebs- Behandlung, Herz-Kreislauf- Behandlung/ Kardiologie
 
22.09.26 - 00:06
Quest Diagnostics Aktie bricht ein: Drohende Kürzungen bei Medicare-Vergütung belasten (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
21.09.26 - 22:48
CMS plant Kürzung der Laborvergütung um 15 %: Umsatzrisiko für Quest Diagnostics und Labcorp (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
21.09.26 - 14:09
Nearly 1 in 3 Patients with Suspected Lyme Disease are Co-Positive for Other Tick-Borne Pathogens, Finds Study by Quest Diagnostics (PR Newswire)
 
Study published in JAMA Network Open of over 193,000 patients nationwide reveals that individuals with evidence of exposure to Borrelia burgdorferi, the bacterium that causes Lyme disease, are more than four times as likely to have antibodies against other tick-borne pathogens compared to......
16.09.26 - 16:45
Quest Diagnostics Incorporated (DGX) Hits Fresh High: Is There Still Room to Run? (Zacks)
 
Quest Diagnostics (DGX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues....
16.09.26 - 14:06
Nine in 10 Voters Express Concern That Medicare Lab Payment Cuts Will Harm Patient Access to Diagnostic Lab Testing, Finds National Survey from Quest Diagnostics (PR Newswire)
 
75% of registered voters surveyed call diagnostic testing "very important" to their care, and a bipartisan majority wants Congress to pass the RESULTS Act before additional Medicare cuts are scheduled to take effect January 2027 SECAUCUS, N.J., Sept. 16, 2026 /PRNewswire/ -- A new......
14.09.26 - 17:30
Quest Diagnostics (DGX) is a Top-Ranked Momentum Stock: Should You Buy? (Zacks)
 
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service....
14.09.26 - 17:06
Quest Diagnostics auf Morgan Stanley Konferenz: Wachstum auf breiter Basis (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
09.09.26 - 22:03
Apple Health app Users to be Able to Order Labs from Quest Diagnostics (PR Newswire)
 
Coming later this year, Apple Health app users will be able to conveniently and securely purchase and receive results of Quest's biomarker lab testing directly in the app SECAUCUS, N.J., Sept. 9, 2026 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX) today announced that Apple Health app......
08.09.26 - 15:48
Quest Diagnostics CEO Sells 10,000 Shares for $2.4 Million (Fool)
 
J. E. Davis disposed of 8% of his direct equity stake under a pre-planned Rule 10b5-1 trading arrangement, retaining $28.9 million in company stock....
04.09.26 - 07:01
Insiderhandel: CEO and President verkauft Aktien von Quest Diagnostics im Wert von 2427200 USD (Insiderkauf)
 
Davis, J. E. - Vorstand - Tag der Transaktion: 2026-09-01...
01.09.26 - 06:01
Insiderhandel: SVP & General Counsel verkauft Aktien von Quest Diagnostics im Wert von 5513083 USD (Insiderkauf)
 
Prevoznik, Michael E. - Vorstand - Tag der Transaktion: 2026-08-28...
25.08.26 - 15:33
Quest Diagnostics to Speak at the Baird 2026 Global Healthcare Conference (PR Newswire)
 
SECAUCUS, N.J., Aug. 25, 2026 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced that Jim Davis, Chairman, CEO and President, will speak on the company's strategy, performance and the latest market developments and trends......
24.08.26 - 13:30
Quest Diagnostics to Offer FDA-Cleared Roche pTau217 Blood Test to Assess Alzheimer′s Disease Pathology (PR Newswire)
 
Test to join the company's expansive portfolio of Quest AD-Detect® blood tests for assessing symptomatic patients Quest also launching a new multi-biomarker AD-Detect® lab-developed blood test with low 10% indeterminate rate, so more patients can receive an actionable insight SECAUCUS,......
21.08.26 - 19:00
Is it the Right Time to Retain DGX Stock in Your Portfolio? (Zacks)
 
Quest Diagnostics' growth across key channels and advanced diagnostics supports its outlook, but debt and reimbursement risks remain....
21.08.26 - 16:45
Quest Diagnostics Incorporated (DGX) Hit a 52 Week High, Can the Run Continue? (Zacks)
 
Quest Diagnostics (DGX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues....
18.08.26 - 19:45
Quest Diagnostics (DGX) Upgraded to Buy: Here′s Why (Zacks)
 
Quest Diagnostics (DGX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term....
17.08.26 - 17:30
Here′s Why Quest Diagnostics (DGX) is a Strong Momentum Stock (Zacks)
 
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service....
14.08.26 - 19:45
Quest Diagnostics (DGX) Is Up 2.29% in One Week: What You Should Know (Zacks)
 
Does Quest Diagnostics (DGX) have what it takes to be a top stock pick for momentum investors? Let's find out....
12.08.26 - 23:03
Quest Diagnostics declares $0.86 dividend (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
12.08.26 - 22:18
Quest Diagnostics Declares Quarterly Cash Dividend (PR Newswire)
 
SECAUCUS, N.J., Aug. 12, 2026 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.86 per share, payable on October 21, 2026 to shareholders of record of Quest......
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Werde nie so reich an Geist, dass arm Du würdest am Herzen! - Otto Ludwig
>Aktienauflistung | >Aktienscreener | >Aktienkennzahlen | >Anleihen | >ETFs | >Fonds | >Branchen | >Länder | >Themen | >Redaktionen
Partner:    >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!